4 Goals for the NFL's Medical Officer By Leah Binder The NFL has the opportunity to be a national leader, ensuring that safety in healthcare comes first in America, on and off the field.
Where Are the New Wearables Heading? By Jeff Pettegrew Wearables could improve health monitoring and safety, but issues like battery life, transparency and simplicity need to be resolved.
Disease Management: Savings at Pepsi Savings were $136 per member per month -- but the wellness/lifestyle management part of the program lost lots of money.
A Smell Test for Wellness Programs By Barry Thompson Surprise! Some restrictive wellness programs will pass that test, but you have to have the right type of workforce and still be careful.
Medical Homes Change the Game On-site clinics have audited results showing they let employers attack both sides of the healthcare equation -- health and health costs.
Are Annual Physicals Really Worthless? How else will people get the screenings that are recommended by authorities and that have been shown to improve health and save lives?
Why Health Insurers Make People Ill If insurers simplified products and trained staff better, they could eliminate scads of customers tirades while saving tons on reps.
Big Disruption That Just Hit Healthcare An insurer has made providers' in-network pricing truly transparent -- finally! -- and the change will likely spread across the country.
Auto Insurance in an Existential Crisis By Stephen Applebaum Alan Demers The 125-year-old, $300 billion U.S. auto insurance industry is caught between runaway inflation and strained consumer wallets.
The Promise of Continuous Underwriting By Bill Deemer Bobby Touran Typically, a risk is underwritten, bound... and forgotten. But new streams of data and automation allow for continuous underwriting.
Convergence and the Insurance Ecosystem By Stephen Applebaum Alan Demers Companies must anticipate the future, innovate beyond their core and transform their capabilities as rapidly as technology allows.
Lemonade's 'Synthetic Agent' Nonsense By Matteo Carbone Desperate for growth, Lemonade produces another howler: A lender receiving a 16% interest rate is presented as a (synthetic) agent.